AAAAAA

   
Results: 1-13 |
Results: 13
ADJUVANT SYSTEMIC THERAPY FOR WOMEN WITH NODE-POSITIVE BREAST-CANCER
Authors: OREILLY SE ALLAN SJ SHENKIER TN GELMON KA LEVINE MN OLIVOTTO IA FIELDS ALA BOWMAN DM BOUCHARD F MCGREGOR M JOLIVET J PRITCHARD KI VERMA S ARJANE GA AYOUB J CHAMPION PE DAVIS ML HICKS S HILLER J HISCOCK J LIEM SK MOHAMED MF TOMIAK EM WARNER E
Citation: Se. Oreilly et al., ADJUVANT SYSTEMIC THERAPY FOR WOMEN WITH NODE-POSITIVE BREAST-CANCER, CMAJ. Canadian Medical Association journal, 158, 1998, pp. 52-64
TREATMENT CONSIDERATIONS IN THE ELDERLY PATIENT WITH LYMPHOMA
Authors: CONNORS JM OREILLY SE
Citation: Jm. Connors et Se. Oreilly, TREATMENT CONSIDERATIONS IN THE ELDERLY PATIENT WITH LYMPHOMA, Hematology/oncology clinics of North America, 11(5), 1997, pp. 949
MALIGNANT-LYMPHOMAS IN THE ELDERLY
Authors: OREILLY SE CONNORS JM MACPHERSON N KLASA R HOSKINS P
Citation: Se. Oreilly et al., MALIGNANT-LYMPHOMAS IN THE ELDERLY, Clinics in geriatric medicine, 13(2), 1997, pp. 251
LATE RELAPSE IN PATIENTS WITH DIFFUSE LARGE-CELL LYMPHOMA TREATED WITH MACOP-B
Authors: LEE AYY CONNORS JM KLIMO P OREILLY SE GASCOYNE RD
Citation: Ayy. Lee et al., LATE RELAPSE IN PATIENTS WITH DIFFUSE LARGE-CELL LYMPHOMA TREATED WITH MACOP-B, Journal of clinical oncology, 15(5), 1997, pp. 1745-1753
TREATMENT OF ADVANCED HODGKINS-DISEASE WITH CHEMOTHERAPY - COMPARISONOF MOPP ABV HYBRID REGIMEN WITH ALTERNATING COURSES OF MOPP AND ABVD - A REPORT FROM THE NATIONAL-CANCER-INSTITUTE OF CANADA CLINICAL-TRIALS GROUP/
Authors: CONNORS JM KLIMO P ADAMS G BURNS BF COOPER I MEYER RM OREILLY SE PATER J QUIRT I SADURA A SHUSTIK C SKILLINGS J SUTCLIFFE S VERMA S YOSHIDA S ZEE B
Citation: Jm. Connors et al., TREATMENT OF ADVANCED HODGKINS-DISEASE WITH CHEMOTHERAPY - COMPARISONOF MOPP ABV HYBRID REGIMEN WITH ALTERNATING COURSES OF MOPP AND ABVD - A REPORT FROM THE NATIONAL-CANCER-INSTITUTE OF CANADA CLINICAL-TRIALS GROUP/, Journal of clinical oncology, 15(4), 1997, pp. 1638-1645
PROGNOSTIC-SIGNIFICANCE OF BCL-2 PROTEIN EXPRESSION AND BCL-2 GENE REARRANGEMENT IN DIFFUSE AGGRESSIVE NON-HODGKINS-LYMPHOMA
Authors: GASCOYNE RD ADOMAT SA KRAJEWSKI S KRAJEWSKA M HORSMAN DE TOLCHER AW OREILLY SE HOSKINS P COLDMAN AJ REED JC CONNORS JM
Citation: Rd. Gascoyne et al., PROGNOSTIC-SIGNIFICANCE OF BCL-2 PROTEIN EXPRESSION AND BCL-2 GENE REARRANGEMENT IN DIFFUSE AGGRESSIVE NON-HODGKINS-LYMPHOMA, Blood, 90(1), 1997, pp. 244-251
PHASE I II TRIAL OF BIWEEKLY PACLITAXEL AND CISPLATIN IN THE TREATMENT OF METASTATIC BREAST-CANCER/
Authors: GELMON KA OREILLY SE TOLCHER AW CAMPBELL C BRYCE C RAGAZ J COPPIN C PLENDERLEITH IH AYERS D MCDERMOTT B NAKASHIMA L HEALEY D ONETTO N
Citation: Ka. Gelmon et al., PHASE I II TRIAL OF BIWEEKLY PACLITAXEL AND CISPLATIN IN THE TREATMENT OF METASTATIC BREAST-CANCER/, Journal of clinical oncology, 14(4), 1996, pp. 1185-1191
BIWEEKLY PACLITAXEL AND CISPLATIN - A PHASE-I II STUDY IN THE FIRST-LINE TREATMENT OF METASTATIC BREAST-CANCER/
Authors: OREILLY SE GELMON KA
Citation: Se. Oreilly et Ka. Gelmon, BIWEEKLY PACLITAXEL AND CISPLATIN - A PHASE-I II STUDY IN THE FIRST-LINE TREATMENT OF METASTATIC BREAST-CANCER/, Seminars in oncology, 22(3), 1995, pp. 109-111
PHOSPHORUS ADSORPTION AND DESORPTION IN A SANDY SOIL AMENDED WITH HIGH-RATES OF COAL FLY-ASH
Authors: OREILLY SE SIMS JT
Citation: Se. Oreilly et Jt. Sims, PHOSPHORUS ADSORPTION AND DESORPTION IN A SANDY SOIL AMENDED WITH HIGH-RATES OF COAL FLY-ASH, Communications in soil science and plant analysis, 26(17-18), 1995, pp. 2983-2993
HIGH-DOSE CYCLOPHOSPHAMIDE, CARMUSTINE (BCNU), AND ETOPOSIDE (VP16-213) WITH OR WITHOUT CISPLATIN (CBV+ -P) AND AUTOLOGOUS TRANSPLANTATION FOR PATIENTS WITH HODGKINS-DISEASE WHO FAIL TO ENTER A COMPLETE REMISSION AFTER COMBINATION CHEMOTHERAPY/
Authors: REECE DE BARNETT MJ SHEPHERD JD HOGGE DE KLASA RJ NANTEL SH SUTHERLAND HJ KLINGEMANN HG FAIREY RN VOSS NJ CONNORS JM OREILLY SE SPINELLI JJ PHILLIPS GL
Citation: De. Reece et al., HIGH-DOSE CYCLOPHOSPHAMIDE, CARMUSTINE (BCNU), AND ETOPOSIDE (VP16-213) WITH OR WITHOUT CISPLATIN (CBV+ -P) AND AUTOLOGOUS TRANSPLANTATION FOR PATIENTS WITH HODGKINS-DISEASE WHO FAIL TO ENTER A COMPLETE REMISSION AFTER COMBINATION CHEMOTHERAPY/, Blood, 86(2), 1995, pp. 451-456
MODERATE-RISK OVARIAN-CANCER (STAGE-I, GRADE-2 - STAGE-II, GRADE-1 ORGRADE-2) TREATED WITH CISPLATIN CHEMOTHERAPY (SINGLE-AGENT OR COMBINATION) AND PELVI-ABDOMINAL IRRADIATION
Authors: HOSKINS PJ SWENERTON KD MANJI M WONG F OREILLY SE MCMURTRIE EJ LE N ACKER B LERICHE J
Citation: Pj. Hoskins et al., MODERATE-RISK OVARIAN-CANCER (STAGE-I, GRADE-2 - STAGE-II, GRADE-1 ORGRADE-2) TREATED WITH CISPLATIN CHEMOTHERAPY (SINGLE-AGENT OR COMBINATION) AND PELVI-ABDOMINAL IRRADIATION, International journal of gynecological cancer, 4(4), 1994, pp. 272-278
PHASE-I TRIAL OF RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR DERIVED FROM YEAST IN PATIENTS WITH BREAST-CANCER RECEIVING CYCLOPHOSPHAMIDE, DOXORUBICIN, AND FLUOROURACIL
Authors: OREILLY SE GELMON KA ONETTO N PARENTE J RUBINGER M PAGE RA PLENDERLEITH IH
Citation: Se. Oreilly et al., PHASE-I TRIAL OF RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR DERIVED FROM YEAST IN PATIENTS WITH BREAST-CANCER RECEIVING CYCLOPHOSPHAMIDE, DOXORUBICIN, AND FLUOROURACIL, Journal of clinical oncology, 11(12), 1993, pp. 2411-2416
IN SEARCH OF AN OPTIMAL REGIMEN FOR ELDERLY PATIENTS WITH ADVANCED-STAGE DIFFUSE LARGE-CELL LYMPHOMA - RESULTS OF A PHASE-II STUDY OF P-DOCE CHEMOTHERAPY
Authors: OREILLY SE CONNORS JM HOWDLE S HOSKINS P KLASA R KLIMO P STUART DS
Citation: Se. Oreilly et al., IN SEARCH OF AN OPTIMAL REGIMEN FOR ELDERLY PATIENTS WITH ADVANCED-STAGE DIFFUSE LARGE-CELL LYMPHOMA - RESULTS OF A PHASE-II STUDY OF P-DOCE CHEMOTHERAPY, Journal of clinical oncology, 11(11), 1993, pp. 2250-2257
Risultati: 1-13 |